Lars Søndergaard, MD, DMSc

Case Report

Transcatheter Valve-in-Valve Implantation due to Severe Aortic Regurgitation in a Degenerated Aortic Homograft

10/13/2009

From the Department of Cardiology, Rigshospitalet, Copenhagen, Denmark. The authors report no conflicts of interest regarding the content herein. Manuscript submitted March 5, 2009, provisional acceptance given April 30, 2009, and final...

From the Department of...

10/13/2009

Journal of Invasive Cardiology

Tips and Techniques

Clinical Outcomes of the Portico Transcatheter Aortic Valve Delivered via Alternative Access: 30-Day and 1-Year Results of the Portico ALT Study

11/01/2020

Holger Thiele , MD, PhD;

Francesco Bedogni , MD, PhD;

Giuseppe Bruschi , MD, PhD;

Axel Linke , MD;

Lars Søndergaard , MD, DMSc;

Marleen van Wely , MD;

Raban V. Jeger , MD, PhD;

Kees van der Wulp , MD;

Joerg Kempfert , MD, PhD;

Christian Schlensak , MD, PhD;

The aim of this study was to report the 30-day and 1-year outcomes and performance from the Portico Alternative Access study to obtain CE approval of the alternative access delivery system.

The aim of this study was to...

11/01/2020

Journal of Invasive Cardiology

Clinical Review

The Rationale for PFO Closure: A Series of Arguments For or Against

08/11/2009

Lars Søndergaard , MD, DMSc;

Carl G.H. Dahlof , MD, PhD;

Peter H. Hannam ;

Abstract During the last decade, patent foramen ovale (PFO) and intermittent or permanent right-to-left shunting of venous blood has been proposed to play a pathogenetic role in a number of disorders. This review covers the most common and...

Abstract During the last...

08/11/2009

Cath Lab Digest

Clinical Review

The Rationale for PFO Closure: A Series of Arguments For or Against

08/11/2009

Lars Søndergaard , MD, DMSc;

Carl G.H. Dahlof , MD, PhD;

Peter H. Hannam ;

Abstract During the last...

08/11/2009

Cath Lab Digest

New-Onset Atrial Fibrillation After Surgical Aortic Valve Replacement and Transcatheter Aortic Valve Implantation: A Concise Review

01/09/2015

Troels Højsgaard Jørgensen , MS;

Julie Bjerre Thygesen , MD;

Hans Gustav Thyregod , MD;

Jesper Hastrup Svendsen , MD, DMSc;

Lars Søndergaard , MD, DMSc;

After surgical aortic valve replacement (SAVR) and transcatheter aortic valve implantation (TAVI), the incidence of new-onset atrial fibrillation (NOAF) is 31%-64% and 4%-32%, respectively. We examine the predisposing factors, optimal...

After surgical aortic valve...

01/09/2015

Journal of Invasive Cardiology

Reevaluation of the Indications for Permanent Pacemaker Implantation After Transcatheter Aortic Valve Implantation

01/29/2014

Jiranut Cholteesupachai , MD;

Poay Huan Loh , MBBS, MD;

Olaf Franzen , MD;

Julie Bjerre Thygesen , MD;

Lars Søndergaard , MD, DMSc;

Conduction abnormalities (CA) requiring permanent pacemaker (PPM) are a well-known complication after transcatheter aortic valve implantation (TAVI). This study aimed to determine the incidence of TAVI-related PPM and reevaluate the...

Conduction abnormalities (CA)...

01/29/2014

Journal of Invasive Cardiology